Information sheet ECTS Syllabus
Course syllabus N431F0_4B - Pharmaceutical Biotechnologies (FCFT - SS 2019/2020)
|University:||Slovak University of Technology in Bratislava|
|Faculty:||Faculty of Chemical and Food Technology|
|Course unit code:||N431F0_4B|
|Course unit title:||Pharmaceutical Biotechnologies|
|Mode of delivery, planned learning activities and teaching methods:|
|Recommended semester/trimester:||Biotechnology - bachelor (semi-compulsory), 6. semester|
|Level of study:||1.|
|Prerequisites for registration:||passed Fundamentals of General Microbiology (N426Z0_4B) and passed Fundamentals of Biochemistry (N426Z1_4B)|
|Students will write test during the semester. The sum of points for the test is 20. Students will successfully pass the test if they earn at least 12 points. Students will get credits for the course if they successfully pass both, the written test and the oral exam. Students are graded as follows: A 48-52 points, B 43-47 points, C 38-42 points, D 33-37 points, E 28-32 points.|
|Learning outcomes of the course unit:|
|Students know specific products focusing on the pharmaceutical, medical and therapeutic properties of numerous biopharmaceutical products.
They have learned microorganisms to create pharmaceuticals.
They understand technological procedures for the commercial production of some microbial products (antibiotics, immunomodulators, enzyme inhibitors).
|Specific products focusing on the pharmaceutical, medical and therapeutic properties of numerous biopharmaceutical products.
Microorganisms to create pharmaceuticals.
Technological procedures for the commercial production of some microbial products (antibiotics, immunomodulators, enzyme inhibitors).
|Recommended or required reading:|
|Language of instruction:||slovak or english|
|Assessed students in total: 37|
|Name of lecturer(s):||prof. Ing. Michal Rosenberg, PhD. (person responsible for course)|
|Last modification:||21. 2. 2019|
|Supervisor:||prof. Ing. Michal Rosenberg, PhD. and programme supervisor|
Last modification made by Ing. Tomáš Molnár on 02/21/2019.